I highly suspect this is going to cost AstraZeneca big.
I highly suspect this is going to cost AstraZeneca big.
UK pro-brexit reporting I have seen has been focusing not on other countries (such as Germany) being upset at the EU's treatment of the UK, but the fact that the EU prevented them from negotiating individually and securing vaccines earlier, and instead imposing additional bureaucracy that delayed the ordering of the vaccine by multiple months.
With the EU introducing export controls against existing (and actually binding) vaccine contracts and now threatening war time-esque controls over production and intellectual property rights of private pharma companies, it is not AstraZeneca that this will cost big, actions like these are much much bigger than uk vs EU
This is the thing. The EU is complaining about AstraZeneca and not the UK itself. AstraZeneca is being accused of transferring supplies from EU factories to UK ones and only providing those to the UK.
> now threatening war time-esque controls over production and intellectual property rights of private pharma companies, it is not AstraZeneca that this will cost big,
I think we think differently on this matter. You think Pharma won't want to deal with the EU if their IP isn't protected. It doesn't matter, another company will enter using their IP and make that money anyways. Their IP being protected is only in the interested of the company, if their IP is not protected they will lose out to generic companies. Doesn't matter where it's developed, someone get it and figure it out and produce it where the IPs are not protected. Drug companies have lots to lose.
Oxford uni and the production plant just happen to be on the other side of the fence right now, there is very little to claim it as a British triumph. They need something to hold onto I guess.
[1] https://twitter.com/BarristersHorse/status/13551877383042539...